London, 18 May 2018 – Independent Clinical Services (ICS) has announced its acquisition of ProClinical Limited on 17 May 2018.
ProClinical is a fast-growing business and valued supplier of highly qualified specialist professionals in both contract and permanent roles to a wide range of customers across the life sciences sector.
ProClinical’s Dan Smart said: "ProClinical has successfully expanded our high-quality services to life sciences customers across the world. We are excited about the future investment and support that ICS will bring which will enable us to build on this track record to develop new services on a truly global scale.”
Commenting on the acquisition Richard MacMillan, CEO of ICS, said: “There is ever-growing demand for professionals with highly sought-after skills across the life sciences sector. With a network of seven offices across five countries, ProClinical complements the ICS life sciences staffing brand, Hobson Prior. The combination of two strong organisations will give ICS an excellent platform to invest and grow in the global life science staffing market. Through Hobson Prior and ProClinical, ICS is now operating in the US, China, Singapore, Australia, Switzerland, Continental Europe and the UK.”
For further information
Independent Clinical Services